Pharmacy

Medicare drug plans are cutting back on coverage for a specially designated type of painkiller that deters abuse in favor of cheaper generics that don't have the same deterrent qualities, a new study found.

Diagnostic tests on urine, blood often cost less than a trip to the movies, as California-based startup aims to take over the market.

Entrepreneur claims direct-to-consumer laboratory testing and price transparency are an integral piece of health reform and a solution to America's disease and cost problems.

Expenses are climbing by 8 percent this year over last, from $416 billion in 2014 to $608 billion in 2015, according to a new report from Kalorama Information.

Depending on how much the program is reformed, it could mean the difference of hundreds of millions of dollars for the thousands of hospitals who get a drug discount.

Kentucky-based pharmacy services business PharMerica will pay $31.5 million to settle a federal lawsuit that it dispensed oxycodone, fentanyl and other narcotics without valid prescriptions and submitted false claims to Medicare Part D for the drugs, according to the company and U.S. Department of Justice.

CVS is planning to open more than 100 new clinics this year -- recent ones opened in Nebraska, New Mexico and Wisconsin -- and could surpass 1,500 locations by 2017.

With Prime's deal dead, and bankruptcy on the horizon, Daughters of Charity executives have several options for possible new deals, including many of the original bidders.

Suit alleged the Denver-based healthcare company over-billed for reimbursement of dialysis drugs.

The Centers for Medicare and Medicaid Services said it was releasing the data to provide greater transparency on what drugs were being prescribed, and by which physicians.